Kellerhals Carrard advised Maestrani Schweizer Schokoladen on taking over the production infrastructure for chocolate-coated marshmallow treats (Schokoladenküsse) from Chocolat Ammann. The context Pursuant to the acquisition, the Swiss family-owned company further expands its brand
Walder Wyss advised Swiss Life in connection with its role as main investor on a CHF 1.2 billion in capital transaction to Swiss Credit Partners. The context As effect of the investment, The FINMA-licensed asset manager
Vischer advised the co-lead and other new investors in Aktiia’s oversubscribed USD 42m Series-B funding-round. Pursuant to the transaction, the blood pressure intelligence platform reached a total funding of USD 100m to date. The
Bratschi advised Solver Advisory andthe sellers in connection with the deal that saw listed company Plazza acquire all shares in A. Schönbächler with retroactive effect as of January 1, 2025. The deal Structured as a
Niederer Kraft Frey (NKF) represented the banking syndicate and Homburger advised consortium leader EQT on the sale of 8.0% of Galderma’s share capital via an accelerated bookbuilding process. The operation On May 27, 2025, a consortium led
Vischer advised GlycoEra in connection with its financing round. The Swiss biotechnology company, closed a USD 130 million Series B funding. BGPartner advised the lead investor Novo Holdings and new investor LifeArc Ventures on all Swiss
Homburger advised Avolta on its role in Dufry One’s issuance of EUR 500 m guaranteed notes. The operation On May 23, 2025, Dufry One issued EUR 500 m 4.50% senior notes, due 2032. Avolta guaranteed the issuance in question,
Homburger advised UBS on four different notes issuance operations starting February 2025. The issuances On February 10, 2025, UBS completed its offering of USD 1,500,000,000 in aggregate principal amount of 7.125% Tier 1 Capital Notes and USD 1,500,000,000 in aggregate principal amount
Kellerhals Carrard advises SKAN on its acquisition of Metronik. The SIX-listed Swiss company, specialised in isolator systems for the (bio-) pharmaceutical industry, has signed an agreement acquire a 76% stake in the Slovenian Metronik, a
Niederer Kraft Frey (NKF) advised PolyPeptide Group on the securing of additional financing under its revolving credit facility, as well as further support from its main shareholder. In connection with the deal, Homburger advised UBS,
